Investigators at Children's Hospital Los Angeles Discover Possible Treatment Option for Drug-Resistant Acute Lymphoblastic Leukemia

Published: Apr 09, 2012

LOS ANGELES--(BUSINESS WIRE)--Nora Heisterkamp, PhD, and Reshmi Parameswaran, PhD, of The Saban Research Institute of Children’s Hospital Los Angeles, have found a novel approach to killing acute lymphoblastic leukemia (ALL) cells. Using a fusion toxin that specifically targets cancer cells, this novel therapeutic may offer a future alternative to patients who become resistant to chemotherapy.

Back to news